KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
Mindset disagrees with and denies the allegations set forth from Reunion.
AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia
Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment
Expands AbbVie's neuroscience portfolio, adding first-in-class modulators of the synaptic vesicle protein 2A, including lead molecule SDI-118 currently in Phase 1b studies
Collaboration aims to develop innovative machine learning and artificial intelligence solutions for personalized and earlier treatment in neurology
Bolstering neuroscience push with late-stage Tourette therapy
Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets
State-of-the-art facility brings next-generation imaging and minimally invasive neurointerventional capabilities to Eastern India
Founded by serial entrepreneur Dinakara Nagalla, the platform enters the Indian market with 30,000 users, and 500 wellbeing professionals
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
